mygmptraining
Claim This Podcastby Shamik (Sam) Pandit
Podcast Overview
<p>Regulations tell you what to do, but 40 years of experience tells you how to do it right the first time. Join us on <strong>mygmptraining </strong>as we pull back the curtain on FDA compliance and quality systems. Whether you’re a seasoned Quality Director or a newcomer to the lab, we provide the insights, pitfalls, and "war stories" necessary to build a culture of compliance that stands up to any audit.</p><p>#GxPTraining #PharmaCompliance #QualitySystems #Biologics #RegulatoryAffairs #FDACompliance #QualityAssurance #PharmaceuticalManufacturing #LifeSciences #GMP #GLP #GCP #PharmaExpert #QualityManagement #AuditReady #BiotechCompliance</p>
Language
🇺🇲
Publishing Since
1/31/2026
Reach the team behind mygmptraining
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
April 8, 2026
High Purity Water System
<p>This episode of the <strong>Deep Dive</strong> podcast navigates the complex regulatory and engineering landscape of <strong>pharmaceutical water systems</strong>, using the <strong>FDA’s July 1993 Inspection Guide</strong> as a foundational roadmap.</p><p><strong>WFI (Water for Injection):</strong> Required for parenteral (injectable) drugs, WFI must be free of <strong>pyrogens</strong>, specifically <strong>endotoxins</strong>—the structural remnants of dead gram-negative bacteria that can cause severe immune responses like anaphylactic shock. It must undergo phase-change (distillation) or reverse osmosis to ensure the absence of endotoxins.</p><p><strong>Purified Water:</strong> High-purity water used for non-sterile applications like oral medications and topicals, requiring stringent microbial control but lower endotoxin thresholds than WFI.</p><p><strong>Process/Potable Water:</strong> The baseline for manufacturing, though vulnerable to environmental contaminants like agricultural runoff.</p><p><strong>Hot vs. Cold Systems:</strong> Hot systems (65–80°C) are self-sanitizing but expensive, while cold systems are prone to <strong>biofilms</strong>—microscopic "coral reefs" of bacteria protected by a slimy polymer matrix.</p><p><strong>Mechanical Vulnerabilities:</strong> The dangers of <strong>dead legs</strong> (unused piping), stagnant water in pump housings, and microscopic crevices in threaded fittings.</p><p><strong>Phase 1 & 2:</strong> Developing and testing Standard Operating Procedures (SOPs) through daily sampling for several weeks.</p><p><strong>Phase 3:</strong> A full year of routine testing to prove the system can handle <strong>seasonality</strong>, such as spring algae blooms or sudden infrastructure shocks like fire department hydrant use.</p><p><strong>The "Action Limit":</strong> Understanding that a spike in data mandates an immediate documented investigation into the root cause, rather than simply "testing into compliance".</p><p><strong>Pyrogens/Endotoxins:</strong> Structural components of dead gram-negative bacteria that can cause severe fevers or anaphylactic shock if they enter the bloodstream.</p><p><strong>LAL (Limulus Amebocyte Lysate) Test:</strong> A biological assay using horseshoe crab blood enzymes to detect and quantify trace amounts of endotoxins.</p><p><strong>Biofilm:</strong> A resilient, microscopic "coral reef" of bacteria that adheres to pipe walls and protects itself with a slimy polymer matrix, making it resistant to standard chemical flushes.</p><p><strong>Dead Leg:</strong> Any unused or stagnant portion of piping where water does not circulate, creating a primary breeding ground for microbial growth.</p><p><strong>Positive Pressure Differential:</strong> An engineering strategy where clean water is kept at a higher pressure than dirty cooling water to ensure that any leaks push clean water out rather than sucking contaminants in.</p><p><strong>SOP (Standard Operating Procedure):</strong> Detailed, mandatory instructions for tasks like valve sequencing or pipe flushing; a failure to follow these can inadvertently suck non-sterile air into a clean system.</p><p><strong>Action Limit:</strong> A specific microbial threshold (e.g., less than 10 CFU per 100ml for WFI) that, if exceeded, requires a documented investigation into the system's root failure.</p><p><strong>Phase 3 Validation:</strong> A full year of routine testing required to prove a system can maintain control across all four seasons and environmental shifts.</p>
March 1, 2026
21 CFR 211 -Subpart B - Organization and Personnel
<p>This presentation outlines the <strong>regulatory requirements</strong> for pharmaceutical <strong>organization and personnel</strong> as defined by <strong>21 CFR Part 211, Subpart B</strong>. It emphasizes the critical role of the <strong>Quality Control Unit</strong>, which possesses the authority to approve or reject all materials and procedures impacting product integrity. The materials specify that <strong>staff and consultants</strong> must be qualified through a blend of education and training while adhering to strict <strong>hygiene and gowning protocols</strong> to prevent contamination. Furthermore, the slides list common <strong>FDA citations</strong>, such as poor supervision and failure to maintain training records, to illustrate the consequences of non-compliance. Ultimately, the course serves as a guide for implementing <strong>cGMP fundamentals</strong> through practical application and rigorous management oversight.</p>
February 10, 2026
Obstructing FDA inspections
<p>This episode outlines <strong>official FDA guidance</strong> regarding the specific behaviors that constitute the <strong>obstruction of drug or device inspections</strong>. Under federal law, if a facility <strong>delays, denies, limits, or refuses</strong> an inspection, the products manufactured there are legally considered <strong>adulterated</strong>. Prohibited actions include <strong>failing to schedule</strong> pre-announced visits, <strong>withholding records</strong>, and <strong>restricting access</strong> to operational areas or photography. While the agency considers <strong>legitimate justifications</strong> for certain disruptions, such as safety protocols or language barriers, it maintains broad authority to ensure <strong>regulatory compliance</strong>.</p><p></p><p>#FDA #RegulatoryCompliance #FDAInspection #Pharma #MedicalDevices #FDALaw #QualityAssurance #AuditReady #LifeSciences #Compliance</p>
5 total episodes available
Deep-dive analytics for mygmptraining
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is mygmptraining?
<p>Regulations tell you what to do, but 40 years of experience tells you how to do it right the first time. Join us on <strong>mygmptraining </strong>as we pull back the curtain on FDA compliance and quality systems. Whether you’re a seasoned Quality Director or a newcomer to the lab, we provide the insights, pitfalls, and "war stories" necessary to build a culture of compliance that stands up to any audit.</p><p>#GxPTraining #PharmaCompliance #QualitySystems #Biologics #RegulatoryAffairs #FDACompliance #QualityAssurance #PharmaceuticalManufacturing #LifeSciences #GMP #GLP #GCP #PharmaExpert #QualityManagement #AuditReady #BiotechCompliance</p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.